FDA grants fast track designation to Wockhardt's novel antibiotic WCK 6777
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
The clinical trial will be conducted at 19 sites with 10,335 participants across India
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech's COVID-19 vaccine Comirnaty unlawfully infringes patents Moderna filed between 2010 and 2016
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
Subscribe To Our Newsletter & Stay Updated